Kathy Costello , Nurse Practitioner
“It might feel like successful adherence is blocked from every direction. Yet, it is not a secret that taking a medication as prescribed is the only way that it will work. Thankfully, there are several actions you can take that will help you keep up with your medications”, says Megan Winebrenner, PharmD, CSP, clinical pharmacy lead at CenterWell Specialty Pharmacy™.
Here are six tips that can help you with adherence:
Check out credible websites like Can Do MS, MSAA, or the National MS Society for unbiased and clear information. Also, ask your healthcare provider lots of questions and be sure that all of them are answered. This will help you be an active participant in the treatment decision-making process. Here are a few questions to get you started.
Here are a few insurance questions you can ask.
When it comes to your MS disease-modifying therapies (DMT), you might find a specialty pharmacy with great team members and resources. They can help you learn more about your medication, how to manage side effects, and how to access drug-cost assistance. Here are a few questions for your pharmacist.
Contact your healthcare provider (HCP) or pharmacist with questions – even if you have already asked them. It is easy to forget or misplace notes, so go ahead and ask again.
If you do not believe you can take a medication, let your HCP know. For example, if you cannot take any time off from your job, an infusion that requires several hours may not work for you. Or if you know that a self-injected medication will be very challenging for you, say something. Let your provider know what you are looking for – what are your goals for the medication and what is important to you. Having your goals, values, and preferences considered will help you adhere to your medication.
If you start the medication and have difficulty taking it, notify your HCP immediately. If side effects are interfering with your daily life, contact your HCP, but also consider a specialty pharmacy like CenterWell Specialty Pharmacy, which has pharmacists and nurses available to help with side-effect management and more.
Over the past four decades, Biogen has been committed to translating science to meaningful advances for the MS community. Our industry-leading portfolio — backed by established safety and efficacy profiles, ongoing investment in our products, as well as our comprehensive services and solutions — enables us to offer a broad range of options to meet the ever-evolving needs of MS patients and drive greater individualized disease management.
Biogen's Patient Resources:
EMD Serono’s experience and scientific discoveries in MS date back more than 20 years. They have an ongoing commitment to improving the entire patient experience. To this end, they offer delivery devices for their therapeutic products as well as comprehensive patient education resources. It is the people living with MS or those who will be diagnosed with MS, their caregivers and healthcare providers who have been their catalyst and inspiration to continue innovating, collaborating and advocating.
EMD Serono's Patient Resources:
Built on patient insights and cutting-edge science and technology, Sanofi is determined to help people living with neurological disorders by developing new treatment options and advancing patient care. With 18 years’ commitment in multiple sclerosis (MS), Sanofi has relentlessly worked to improve the lives of the 2.3 million people worldwide living with this serious, life-long neuro-degenerative disease. Since the launch of its portfolio in 2012, Sanofi has rapidly emerged as a leader in MS, bringing two therapies to patients in more than 80 countries worldwide. There is significant work left to be done, and Sanofi is committed to accelerating the development of potential treatments for MS, amyotrophic later sclerosis, and other neurological diseases.
Sanofi's Patient Resources:
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Genentech's Patient Resources:
This material is provided for informational use only and should not be construed as medical advice or used in place of consulting a licensed medical professional. Links to various other websites from this site are provided for your convenience only. Can Do MS disclaims responsibility for their content and accuracy.